Leaders of the Committee on Energy and Commerce threatened to subpoena the Food and Drug Administration (FDA) for records the agency used in determining that the chemical bisphenol A (BPA) was safe for use in making infant formula liners and other products intended for infants and children.
In an April 4 letter to the FDA, committee chairman Rep John D. Dingell (D, Mich) and Rep Bart Stupak (D, Mich), chairman of the subcommittee on oversight and investigations, wanted to know why it appears the agency's position on BPA safety is based entirely on 2 studies funded by the American Plastics Council—one of which has not been published or peer reviewed. The legislators said some scientists have raised concerns that the chemical could contribute to diabetes, cancer, and obesity.
Mitka M. Baby Bottle Safety. JAMA. 2008;299(18):2141. doi:10.1001/jama.299.18.2141-b
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: